These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2887475)

  • 1. Combination treatment: colloidal bismuth subcitrate with H2-antagonists.
    Salmon PR
    Digestion; 1987; 37 Suppl 2():42-6. PubMed ID: 2887475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease.
    Bianchi Porro G; Lazzaroni M; Cortvriendt WR
    Digestion; 1987; 37 Suppl 2():47-52. PubMed ID: 3305118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal bismuth subcitrate and two different dosages of cimetidine in the treatment of resistant duodenal ulcer. Preliminary results.
    Bianchi Porro G; Parente F; Lazzaroni M; Pace F
    Scand J Gastroenterol Suppl; 1986; 122():39-41. PubMed ID: 2877490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
    Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
    Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
    Bayerdörffer E; Mannes GA; Pfaller P; Sauerbruch T
    Internist (Berl); 1989 Jun; 30(6):390-2. PubMed ID: 2668217
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.
    Vantrappen G; Rutgeerts P; Broeckaert L; Janssens J
    Gut; 1980 Apr; 21(4):329-33. PubMed ID: 7000628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin versus cimetidine or De-Nol in gastric ulcer treatment. An endoscopically controlled trial.
    Janke A; Badurski J; Stasiewicz J; Sajewicz I; Namiot Z
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(5):239-43. PubMed ID: 3075178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of colloidal bismuth subcitrate tablets and ranitidine in the treatment of chronic duodenal ulcers.
    Ward M; Halliday C; Cowen AE
    Digestion; 1986; 34(3):173-7. PubMed ID: 3530861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic duodenal ulceration. Effectiveness of colloidal bismuth subcitrate tablets compared with cimetidine.
    Harley H; Alp MH
    Med J Aust; 1983 Dec 10-24; 2(12):627-8. PubMed ID: 6366498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
    Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.
    Pan SA; Liao CH; Lien GS; Chen SH
    Gastroenterology; 1991 Nov; 101(5):1187-91. PubMed ID: 1936788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN
    S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
    Wilson P; Alp MH
    Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of colloidal bismuth subcitrate on duodenal ulcer relapse.
    Bianchi Porro B; Lazzaroni M; Parente F; Petrillo M
    Scand J Gastroenterol Suppl; 1986; 122():35-8. PubMed ID: 3535020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
    Barbara L; Corinaldesi R; Rea E; Paternicò A; Stanghellini V
    Scand J Gastroenterol Suppl; 1986; 122():30-4. PubMed ID: 3535019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine.
    Bianchi Porro G; Lazzaroni M; Petrillo M; De Nicola C
    Lancet; 1984 Sep; 2(8404):698. PubMed ID: 6147723
    [No Abstract]   [Full Text] [Related]  

  • 20. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
    Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
    J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.